Humacyte Inc (HUMA)
4.40
+0.48
(+12.24%)
USD |
NASDAQ |
May 01, 16:00
4.39
-0.01
(-0.23%)
After-Hours: 19:30
Humacyte Price to Book Value: 38.68 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 34.46 |
April 29, 2024 | 35.96 |
April 26, 2024 | 35.08 |
April 25, 2024 | 34.29 |
April 24, 2024 | 33.58 |
April 23, 2024 | 34.55 |
April 22, 2024 | 32.53 |
April 19, 2024 | 32.53 |
April 18, 2024 | 31.56 |
April 17, 2024 | 27.43 |
April 16, 2024 | 26.90 |
April 15, 2024 | 25.23 |
April 12, 2024 | 25.32 |
April 11, 2024 | 26.55 |
April 10, 2024 | 26.29 |
April 09, 2024 | 26.72 |
April 08, 2024 | 27.25 |
April 05, 2024 | 26.72 |
April 04, 2024 | 27.43 |
April 03, 2024 | 26.64 |
April 02, 2024 | 26.11 |
April 01, 2024 | 26.46 |
March 28, 2024 | 27.34 |
March 27, 2024 | 27.25 |
March 26, 2024 | 26.99 |
Date | Value |
---|---|
March 25, 2024 | 27.60 |
March 22, 2024 | 29.10 |
March 21, 2024 | 31.65 |
March 20, 2024 | 30.31 |
March 19, 2024 | 30.14 |
March 18, 2024 | 30.31 |
March 15, 2024 | 27.98 |
March 14, 2024 | 27.29 |
March 13, 2024 | 28.41 |
March 12, 2024 | 28.58 |
March 11, 2024 | 26.86 |
March 08, 2024 | 29.10 |
March 07, 2024 | 28.24 |
March 06, 2024 | 29.10 |
March 05, 2024 | 30.05 |
March 04, 2024 | 27.02 |
March 01, 2024 | 24.80 |
February 29, 2024 | 33.29 |
February 28, 2024 | 33.68 |
February 27, 2024 | 34.67 |
February 26, 2024 | 34.75 |
February 23, 2024 | 33.14 |
February 22, 2024 | 32.95 |
February 21, 2024 | 32.45 |
February 20, 2024 | 37.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.755
Minimum
Dec 28 2022
38.68
Maximum
May 01 2024
8.350
Average
5.059
Median
Jul 21 2023
Price to Book Value Benchmarks
Adial Pharmaceuticals Inc | 1.748 |
Gritstone Bio Inc | 1.661 |
Precision BioSciences Inc | 3.872 |
Puma Biotechnology Inc | 4.443 |
Revance Therapeutics Inc | -- |
Price to Book Value Related Metrics
Price | 4.40 |
Earnings Yield | -24.32% |
Market Cap | 523.97M |